Identification of Clinical and Demographic Predictors for Treatment Modality in Patients With Carpal Tunnel Syndrome.

Abstract

Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy. There are multiple treatment modalities for CTS. This study examines both clinical and demographic predictors for initial treatment modality of CTS. Patients diagnosed with CTS between February 2015 and October 2020 with a hand clinic visit within 6 weeks before treatment were included in our study. Patients completed Patient-Reported Outcomes Measurement Information System Pain Interference, Physical Function, and Depression and had complete data on relevant predictor variables. Primary outcomes were treatment group: (1) injection only; (2) release only; and (3) injection followed by release. Bivariate analyses and multinomial logistic regression was used to identify statistically significant variables and independent predictors associated with the treatment groups, respectively. A total of 1409 patients fit our inclusion criteria. Sex, age, body mass index (BMI), race, ethnicity, Pain Interference, and Depression were statistically significant predictors for treatment group in bivariate analysis (<i>P</i> < .05). In multivariable analysis, adults older than 65 years were less likely to receive either injection only or injection followed by release (odds ratio [OR]: 0.56 and OR: 0.52, respectively; <i>P</i> < .01). Overweight (BMI: ≥25) individuals were less likely to receive injection only (OR: 0.45; <i>P</i> < .01). Women were more likely to have either injection only or injection followed by released (OR: 1.50 and 1.55; <i>P</i> < .01). Similarly, black, Indigenous, or Persons of Color had an increased odds of injection only and injection followed by release (OR: 1.61 and OR: 1.69, respectively; <i>P</i> < .05). Sex, age, BMI, race, and ethnicity were found to be independent predictors of treatment modality for CTS.